Amylin Pharmaceuticals Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON(TM). In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests...

MannKind Corporation announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA(TM)   Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes. The Complete Response letter...

Diamyd Medical announced that 100 patients are now enrolled in the company’s US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA and more sites are to be added. The study will include 320 children and adolescents between 10 and 20 years of age, recently diagnosed with type 1 diabetes. To date more...

The Food and Drug Administration (FDA) announced that following the closure of FDA building due to extreme weather it was granting a five day extension for the review of Amylin Pharmaceuticals Inc and Eli Lilly and Co’s Exenatide Once Weekly New Drug Application. The new drug is part of a collaboration between the companies...

According to a new study, published in the journal Maturitas, by a team of researchers at Warwick Medical School, middle aged and elderly people with high levels of vitamin D could reduce their chances of developing heart disease or diabetes by 43%. The researchers looked at 28 studies including 99,745 participants across a variety...

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will  advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin)  and metreleptin  (an...

Using stem cells from a patient’s own body fat, scientists have been able to reverse symptoms of multiple sclerosis , reports Telegraph.  MS, an autoimmune disease, is caused by the destruction of myelin, a fatty protective sheath surrounding the body’s central nervous system.  These preliminary findings, based on three...

Researchers found that dolphins can induce diabetes when there is little food around and turn it off when food is abundant, according to Telegraph. They believe this is a unique ability in the animal kingdom and results from the dolphin’s need to maintain high blood sugar levels to feed its big brain.  They also believe it is an...

Diabetes Care reports on a new study which shows vinegar reduces post-meal hyperglycemia in type 1 diabetics.  While previous studies have shown that vinegar improves insulin sensitivity in healthy or insulin-resistant subjects, information on the effect of vinegar in type 1 diabetes has been absent. Subjects in the study, tested under...

Japanese scientists say they’ve identified the cause of early rejection of transplanted pancreatic islet cells used in treating type 1 diabetes. According to a UPI report, researchers at the Riken Institute and Fukuoka University said their discovery sets the stage for development of treatment technique which could be four times...